Spyre Therapeutics
SYRE
SYRE
103 hedge funds and large institutions have $1.21B invested in Spyre Therapeutics in 2024 Q1 according to their latest regulatory filings, with 55 funds opening new positions, 20 increasing their positions, 15 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
103
Holders Change
+49
Holders Change %
+90.74%
% of All Funds
1.49%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.07%
New
55
Increased
20
Reduced
15
Closed
6
Calls
$76K
Puts
–
Net Calls
+$76K
Net Calls Change
+$32K
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$105M |
| 2 |
BlackRock
New York
|
+$20.4M |
| 3 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
+$17.9M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$17.7M |
| 5 |
FTM
First Turn Management
Del Mar,
California
|
+$17.6M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
101
JPMorgan Chase & Co
New York
| $417 | -$1.14K | -30 | -73% |
|
|
PCWA
102
Pacific Capital Wealth Advisors
Corona,
California
| $303 | – | – | – |
|
103
Macquarie Group
Sydney, NSW 2000,
Australia
| $96 | +$96 | +2,523 | New |
|
|
EC
104
EcoR1 Capital
San Francisco,
California
| – | -$19.1M | -887,076 | Closed |
|
|
BI
105
BVF Inc
San Francisco,
California
| – | -$14.8M | -687,080 | Closed |
|
|
UONDDL
106
University of Notre Dame du Lac
South Bend,
Indiana
| – | -$12.4M | -577,616 | Closed |
|
|
PM
107
Prosight Management
Dallas,
Texas
| – | -$1.18M | -55,000 | Closed |
|
108
Acadian Asset Management
Boston,
Massachusetts
| – | -$25K | -1,169 | Closed |
|
|
PA
109
Parallel Advisors
San Francisco,
California
| – | -$22 | -1 | Closed |
|